In contrast, treatment with the more hydrophobic biguanide phenformin, which did enter the thymus and activate AMPK, delayed the onset of T-ALL but only if AMPK was present in the developing T cells (Figure 5). Here, PRKAA2 is linked to acute lymphoblastic leukemia.